why choose us

First received: January 26, 2023

Clinical Trial: A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Myelofibrosis Due to and Following Polycythemia Vera

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of Ruxolitinib Plus Abemaciclib for Patients With Primary or Post-polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Brief Summary: The study is being done to see if the combination of ruxolitinib and abemaciclib is a safe and effective treatment for people with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis.

Read more